Article
The Epigenetic promise for prostate cancer diagnosis
7 Dec 2011
Abstract excerpt
BACKGROUND: Prostate cancer is the most common cancer diagnosis in men and a leading cause of death. Improvements in disease management would have a significant impact and could be facilitated by the development of biomarkers, whether for diagnostic, prognostic, or predictive purposes. The blood-based prostate biomarker PSA has been part of clinical practice for over two decades, although it is surrounded by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
